Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.87 USD | -0.76% |
|
+7.86% | +25.71% |
06-13 | Baird Initiates Lexeo Therapeutics With Outperform Rating, $28 Price Target | MT |
06-06 | HC Wainwright Initiates Lexeo Therapeutics at Buy With $22 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.71% | 556M | |
+38.36% | 52.73B | |
+36.73% | 39B | |
-8.63% | 38.52B | |
+25.46% | 30.38B | |
-11.17% | 26.39B | |
+11.44% | 26.08B | |
+45.09% | 14.15B | |
+32.93% | 12.6B | |
-5.30% | 11.51B |
- Stock Market
- Equities
- LXEO Stock
- News Lexeo Therapeutics, Inc.
- HC Wainwright Initiates Lexeo Therapeutics at Buy With $22 Price Target